Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib
Clinical trial NCT05020964 · UNKNOWN
Trial details
- NCT number
- NCT05020964
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2022-09-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.